MEK5/ERK5 inhibition sensitizes NRAS-mutant melanoma to MAPK-targeted therapy by preventing Cyclin D/CDK4-mediated G1/S progression
Rupesh Paudel(Universitätsklinikum Würzburg), Marc Schmidt(Universitätsklinikum Würzburg), Matthias Goebeler(University of Würzburg), Simon Goller(Universitätsklinikum Würzburg), Felix Deutzmann(Universitätsklinikum Würzburg), David Schrama(Universitätsklinikum Würzburg), Andrea Knorz(Universitätsklinikum Würzburg), Katharina Meder(Universitätsklinikum Würzburg)
Cited by 4
Related Papers
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332
How Does the Eye Breathe?
|Journal of Biological Chemistry|2003|314
Neuroglobin and cytoglobin in search of their role in the vertebrate globin family
|Journal of Inorganic Biochemistry|2004|298
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
|Journal of the European Academy of Dermatology and Venereology|2022|247
Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts
|European Journal of Cancer|2021|246